Molecular analysis of rifampin and isoniazid resistance of Mycobacterium tuberculosis clinical isolates in Seville, Spain
- 1 June 1999
- journal article
- Published by Elsevier in Tubercle and Lung Disease
- Vol. 79 (3) , 187-190
- https://doi.org/10.1054/tuld.1998.0195
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Inhibition of a Mycobacterium tuberculosis β-Ketoacyl ACP Synthase by IsoniazidScience, 1998
- Analysis of ahpC gene mutations in isoniazid-resistant clinical isolates of Mycobacterium tuberculosisAntimicrobial Agents and Chemotherapy, 1997
- Compensatory ahp C Gene Expression in Isoniazid-Resistant Mycobacterium tuberculosis Science, 1996
- ahpC, a gene involved in isoniazid resistance of the Mycobacterium tuberculosis complexMolecular Microbiology, 1996
- Antimicrobial agent resistance in mycobacteria: molecular genetic insightsClinical Microbiology Reviews, 1995
- Molecular Mechanisms of Multiple Drug Resistance in Clinical Isolates of Mycobacterium tuberculosisThe Journal of Infectious Diseases, 1995
- Rapid Identification Of A Point Mutation Of The Mycobacterium tuberculosis Catalase-Peroxidase (katG) Gene Associated With Isoniazid ResistanceThe Journal of Infectious Diseases, 1995
- Implications of multidrug resistance for the future of short-course chemotherapy of tuberculosis: a molecular studyThe Lancet, 1994
- inhA , a Gene Encoding a Target for Isoniazid and Ethionamide in Mycobacterium tuberculosisScience, 1994
- The catalase—peroxidase gene and isoniazid resistance of Mycobacterium tuberculosisNature, 1992